MDAI Spectral AI, Inc.
Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1833498 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-37.6%
TTM net income YoY37.7%
TTM EPS YoY60.0%
Revenue 3-yr CAGR-8.5%
Net income 3-yr CAGR—
Margins
Gross margin39.9%
Operating margin-86.5%
Net margin-70.5%
FCF margin—
EBITDA margin-85.7%
Returns
ROE—
ROA-64.0%
ROIC (approx.)—
Asset turnover0.91x
Leverage & solvency
Liabilities / assets193.2%
Debt / equity—
Current ratio0.63x
Interest coverage-6.86x
Cash quality & payout
Operating cash flow / net income1.28x
Accruals ratio17.8%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $19.65M | $29.58M | $18.06M | $25.37M | — |
| Cost of revenue | $10.72M | $16.31M | $10.18M | $14.53M | — |
| Gross profit | $8.93M | $13.27M | $7.88M | $10.84M | — |
| R&D expense | — | — | $15.10M | $16.50M | — |
| SG&A expense | $17.53M | $19.86M | $20.86M | $13.48M | $3.42M |
| Operating income | -$8.60M | -$6.58M | -$12.98M | -$2.65M | -$3.42M |
| Interest expense | $886,000 | -$14,000 | — | — | — |
| Pretax income | -$7.56M | -$15.04M | -$20.84M | -$2.81M | -$2.15M |
| Income tax | $11,000 | $114,000 | $11,000 | $106,000 | $0 |
| Net income | -$7.57M | -$15.16M | -$20.85M | -$2.91M | -$2.15M |
| EBITDA | -$8.53M | -$6.57M | -$12.97M | -$2.64M | — |
| EPS (basic) | -0.29 | -0.85 | -1.48 | -0.22 | — |
| EPS (diluted) | -0.29 | -0.85 | -1.48 | -0.22 | — |
| Weighted avg. shares (diluted) | 26.52M | 17.93M | 14.09M | 13.14M | — |
| Banking | |||||
| Net interest income | — | — | — | $12.90M | $1.27M |
| Balance sheet | |||||
| Cash & equivalents | $15.40M | $5.16M | $4.79M | $14.17M | $16.12M |
| Receivables | $1.27M | $2.50M | $2.35M | $2.29M | — |
| Inventory | $838,000 | $425,000 | $230,000 | — | — |
| Current assets | $19.45M | $10.12M | $9.90M | $17.69M | $1.08M |
| PP&E, net | $258,000 | $2,000 | $12,000 | $21,000 | — |
| Total assets | $21.41M | $12.10M | $10.69M | $18.72M | $254.11M |
| Current liabilities | $20.63M | $17.64M | $12.40M | $6.37M | $2.94M |
| Long-term debt | $5.54M | $2.79M | — | — | — |
| Total debt | $5.54M | $2.79M | — | — | — |
| Total liabilities | $27.13M | $19.35M | $12.40M | $6.72M | $21.93M |
| Shareholders' equity | -$5.73M | -$7.25M | -$2.15M | $12.00M | $13.75M |
| Net debt | -$9.86M | -$2.37M | — | — | — |
| Shares outstanding | 30.69M | 22.59M | 16.29M | 13.17M | — |
| Cash flow statement | |||||
| Operating cash flow | -$9.92M | -$9.20M | -$13.24M | -$1.16M | -$825,593 |
| Investing cash flow | — | — | — | $251.56M | -$253.00M |
| Financing cash flow | $20.12M | $9.57M | $3.84M | -$785,000 | $254.60M |
| Depreciation & amortization | $71,000 | $10,000 | $9,000 | $11,000 | — |
| Stock-based compensation | $1.11M | $1.03M | $1.24M | $1.16M | — |
| Share buybacks | — | — | — | $250.52M | $0 |
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.